Neurological Disorders in Takotsubo Syndrome: Clinical Phenotypes and Outcomes
Francesco Santoro,Iván J Núñez Gil,Luca Arcari,Enrica Vitale,Tommaso Martino,Ibrahim El-Battrawy,Federico Guerra,Giuseppina Novo,Enrica Mariano,Beatrice Musumeci,Luca Cacciotti,Pasquale Caldarola,Roberta Montisci,Ilaria Ragnatela,Rosa Cetera,Oscar Vedia,Emilia Blanco,Javier Lopez Pais,Agustin Martin,Alberto Pérez-Castellanos,Jorge Salamanca,Francesco Bartolomucci,Ibrahim Akin,Holger Thiele,Ingo Eitel,Thomas Stiermaier,Natale Daniele Brunetti
DOI: https://doi.org/10.1161/JAHA.123.032128
2024-02-20
Abstract:Background: Neurological disorders as a risk factor for Takotsubo syndrome (TTS) are not well characterized. The aim of the study was to evaluate TTS-associated neurological phenotypes and outcome. Methods and results: Patients with TTS enrolled in the international multicenter GEIST (German Italian Spanish Takotsubo) registry were analyzed. Prevalence, clinical characteristics, and short- and long-term outcomes of patients with TTS were recorded. A subgroup analysis of the 5 most represented neurological disorders was performed. In total, 400 (17%) of 2301 patients had neurological disorders. The most represented neurological conditions were previous cerebrovascular events (39%), followed by neurodegenerative disorders (30.7%), migraine (10%), epilepsy (9.5%), and brain tumors (5%). During hospitalization, patients with neurological disorders had longer in-hospital stay (8 [interquartile range, 5-12] versus 6 [interquartile range, 5-9] days; P<0.01) and more often experienced in-hospital complications (27% versus 16%; P=0.01) mainly driven by cardiogenic shock and in-hospital death (12% versus 7.6% and 6.5% versus 2.8%, respectively; both P<0.01). Survival analysis showed a higher mortality rate in neurological patients both at 60 days and long-term (8.8% versus 3.4% and 23.5% versus 10.1%, respectively; both P<0.01). Neurological disorder was an independent predictor of both the 60-day and long-term mortality rate (odds ratio, 1.78 [95% CI, 1.07-2.97]; P=0.02; hazard ratio, 1.72 [95% CI, 1.33-2.22]; both P<0.001). Patients with neurodegenerative disorders had the worst prognosis among the neurological disease subgroups, whereas patients with TTS with migraine had a favorable prognosis (long-term mortality rates, 29.2% and 9.7%, respectively). Conclusions: Neurological disorders identify a high-risk TTS subgroup for enhanced short- and long-term mortality rate. Careful recognition of neurological disorders and phenotype is therefore needed.